Michelle Bell

EyeYon Medical's synthetic corneal implant, EndoArt, just got FDA approval for U.S. trials, offering a fix for the global donor tissue shortage.

With a fresh $62M in funding, WELLSTAR is accelerating its AI and acquisition strategy ahead of a planned 2026 spinout, aiming to rewire Canadian healthcare.

A breakthrough drug for a rare brain cancer sweeps prestigious international awards, offering patients a new, targeted therapy to delay aggressive treatments.

A breakthrough eco-friendly antioxidant, SA6000, could slash the environmental impact of tires. But can this molecular innovation scale for global impact?

Plume Network launches institutional-grade asset vaults on Solana, connecting giants like WisdomTree to high-speed DeFi and forging a new era of real-world yield.

Seegene expands to France's lucrative diagnostics market, but the real story is its plan to build an automated, data-driven health intelligence network.

Kayou's aggressive push into Southeast Asia's collectibles market reveals a sophisticated strategy built on digital networks and hyper-local engagement.

Amid currency crises, Continental Reinsurance shores up its finances with a bold offshore investment strategy, offering a model for stability in Africa.

SoftBank's move to delist French robotics firm BALYO offers a premium to shareholders but signals a larger consolidation in the automated logistics space.

Beyond the award, we explore Diebold Nixdorf's ESG data, the rise of corporate responsibility rankings, and why sustainability is now core business strategy.

High internet penetration and modern regulations are creating a fertile digital market, with Expanse Studios' recent expansion showing the way.

Beyond 200,000 houses, Meritage Homes' focus on energy efficiency and affordability is laying the foundational infrastructure for our connected future.

Beyond ports and destinations, Oceania Cruises is building a new kind of infrastructure—one of taste—on its upcoming ship, setting a new bar for luxury mobility.

Final data from Elevar Therapeutics' Phase 3 trial, published in The Lancet Oncology, shows a major survival boost for a deadly form of liver cancer.

Infinix, a fast-growing tech giant, partners with legendary car designer Pininfarina. Can Italian elegance redefine the smartphone and our digital lives?

How one advisory firm's $100K Giving Tuesday grant reveals a deeper strategy of employee-led philanthropy and strategic brand building.

Habanos S.A. unveils the Diplomáticos Cancilleres in Sofia, a strategic launch blending Cuban heritage with a bold push into Eastern Europe's market.

A landmark deal for fertilizer giant Profertil reveals a strategic play to control the infrastructure of food production, from natural gas to the dinner plate.

A UK-US team has unlocked a scalable method to create nuclear fuel from americium, paving the way for long-duration missions to the Moon and deep space.

A junior miner with vast Quebec graphite reserves appoints a finance veteran. Is this the move that unlocks a key piece of North America's EV supply chain?